Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder [Phase 4]
Phase 4 clinical trial assessing changes in cerebral glucose metabolism after 12 weeks of escitalopram treatment in Panic Disorder; the stud…
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: Changes of Cerebral Glucose Metabolism After 12 Weeks of Paroxetine Treatment in Panic Disorder [Phase 4]
Phase 4 clinical trial evaluating changes in cerebral glucose metabolism after 12 weeks of paroxetine treatment in patients with panic disor…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Personality-targeted Interventions for Adolescent Alcohol Misuse [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating personality-targeted interventions for adolescent alcohol misuse, sponsored by King's College L…
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial from King's College London testing a teacher-delivered, personality-targeted intervention for substance m…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
This completed clinical trial evaluated changes in metabolic parameters in patients with major depressive disorder, generalized anxiety diso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-07FDA Approved: ALPRAZOLAM — Original Application (Aurobindo Pharma Limited)
FDA approved a generic alprazolam product from Aurobindo Pharma Limited under an Original Application (ANDA).
-
FDA approval · 2011-06-01FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alprazolam from Mylan Pharmaceuticals, authorizing a generic alprazolam product. The approva…
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder [Phase 4]
Phase 4 trial comparing sertraline with paroxetine for panic disorder has completed with results posted.
-
FDA approval · 2011-05-06FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Dr.Reddys Laboratories Inc)
FDA approved the original ANDA for Venlafaxine hydrochloride by Dr. Reddy's Laboratories Inc, enabling a generic version of this antidepress…
-
CLINICAL_TRIALS research · 2011-05-02Clinical Trial Update: Using Smart Phone Technology To Rural Veterans [NA]
This clinical trial update describes a study evaluating smartphone technology to assist rural veterans with panic and anxiety disorders.
-
CLINICAL_TRIALS research · 2011-05-02Clinical Trial Update: Improving Access To Services to Community Based Outpatient Clinics (CBOC's) [NA]
This clinical trial update from Michael E. DeBakey VA Medical Center concerns improving access to services at Community Based Outpatient Cli…
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Efficacy of Treatment for Panic Disorder
A completed clinical trial from the University of British Columbia evaluating the efficacy of a treatment for Panic Disorder. The snippet do…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original ANDA for venlafaxine hydrochloride from Zydus Pharmaceuticals USA Inc., authorizing a generic version of the antid…
-
FDA approval · 2011-04-14FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original ANDA for venlafaxine hydrochloride, a generic antidepressant.
-
CLINICAL_TRIALS research · 2011-04-11Clinical Trial Update: Mechanisms of Panic Disorders Treatment [Phase 2, Phase 3]
This update reports on an ongoing Phase 2/Phase 3 clinical trial investigating mechanisms of treatment for panic disorder and agoraphobia.
-
FDA approval · 2011-04-08FDA Approved: CLONAZEPAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for clonazepam filed by Aurobindo Pharma Limited under ANDA075150.
-
FDA approval · 2011-03-14FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for sertraline hydrochloride from Aurobindo Pharma Limited, enabling its generic product.
-
FDA approval · 2011-03-04FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride from Zydus Lifesciences Limited.
-
FDA approval · 2011-01-30FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Paroxetine hydrochloride by Zydus Lifesciences Limited, indicating an update to the labeling or …
-
FDA approval · 2010-12-14FDA Approved: VENLAFAXINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic venlafaxine via an Original Application (ANDA). It is indicated for major depressive disorder,…
-
FDA approval · 2010-12-10FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for paroxetine hydrochloride (paroxetine) submitted by NorthStar Rx LLC. This action represents an a…
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks [NA]
A completed single-blind trial comparing risperidone to paroxetine for treatment of panic attacks in people with major depressive disorder w…
-
FDA approval · 2010-10-15FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride (generic) from Zydus Lifesciences Limited, authorizing a generic paroxe…
-
FDA label_change · 2010-09-20FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluoxetine hydrochloride by PAI Holdings to modify the product labeling.
-
FDA approval · 2010-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic venlafaxine hydrochloride under an Original Application. It is indicated for major depre…